Yun-Cheol Na

Yun-Cheol Na

Auto-generated profile, based on publicly available information

Yun-Cheol Na

Metropolitan Seoul Center Korea Basic Science Institute Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
HSHan Song
Han Song
YYYoung Yoo
Young Yoo
JHJunghyun Hwang
Junghyun Hwang
YNYun-Cheol Na
Yun-Cheol Na
HKHeenam Stanley Kim
Heenam Stanley Kim
Atopic dermatitis (AD) is a serious global epidemic associated with a modern lifestyle. Although aberrant interactions between gut microbes and the intestinal immune system have been implicated in this skin disease, the nature of the microbiome dysfunction underlying the disease remains unclear. The gut microbiome from 132 subjects, including 90 patients with AD, was analyzed by using 16S rRNA gene and metagenome sequence analyses. Reference genomes from the Human Microbiome Project and the KEGG Orthology database were used for metagenome analyses. Short-chain fatty acids in fecal samples were compared by using gas chromatographic-mass spectrometric analyses. We show that enrichment of a subspecies of the major gut species Faecalibacterium prausnitzii is strongly associated with AD. In addition, the AD microbiome was enriched in genes encoding the use of various nutrients that could be released from damaged gut epithelium, reflecting a bloom of auxotrophic bacteria. Fecal samples from patients with AD showed decreased levels of butyrate and propionate, which have anti-inflammatory effects. This is likely a consequence of an intraspecies compositional change in F prausnitzii that reduces the number of high butyrate and propionate producers, including those related to the strain A2-165, a lack of which has been implicated in patients with Crohn disease. The data suggest that feedback interactions between dysbiosis in F prausnitzii and dysregulation of gut epithelial inflammation might underlie the chronic progression of AD by resulting in impairment of the gut epithelial barrier, which ultimately leads to aberrant TH2-type immune responses to allergens in the skin.

16 February 2011 in Organic Letters
Verified
Journal Article
Closed access
HJHyo Sung Jung
Hyo Sung Jung
KKKyoung Chul Ko
Kyoung Chul Ko
GKGun-Hee Kim
Gun-Hee Kim
ALAh-Rah Lee
Ah-Rah Lee
YNYun-Cheol Na
Yun-Cheol Na
Jong Seung KimJong Seung Kim
Jong Seung Kim

1 June 2007 in Journal of Chromatography A
Verified
Journal Article
Closed access
YHYoung Wan Ha
Young Wan Ha
SLSoon Sung Lim
Soon Sung Lim
In Jin HaIn Jin Ha
In Jin Ha
YNYun-Cheol Na
Yun-Cheol Na
JSJung-Ju Seo
Jung-Ju Seo
YKYeong Shik Kim
Yeong Shik Kim

1 November 2006 in Journal of Chromatography A
Verified
Journal Article
Closed access
YHYoung Wan Ha
Young Wan Ha
YNYun-Cheol Na
Yun-Cheol Na
JSJung-Ju Seo
Jung-Ju Seo
SKSoo-Na Kim
Soo-Na Kim
RLRobert J. Linhardt
Robert J. Linhardt
YKYeong Shik Kim
Yeong Shik Kim

17 December 2015 in Scientific Reports
Verified
Journal Article
Open access
KKKi-Suk Kim
Ki-Suk Kim
HYHea Jung Yang
Hea Jung Yang
ILIn-Seung Lee
In-Seung Lee
KKKang-Hoon Kim
Kang-Hoon Kim
JPJiyoung Park
Jiyoung Park
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang
Ginsenosides can be classified on the basis of the skeleton of their aglycones. Here, we hypothesized that the sugar moieties attached to the dammarane backbone enable binding of the ginsenosides to the sweet taste receptor, eliciting glucagon-like peptide-1 (GLP-1) secretion in the enteroendocrine L cells. Using the human enteroendocrine NCI-H716 cells, we demonstrated that 15 ginsenosides stimulate GLP-1 secretion according to the position of their sugar moieties. Through a pharmacological approach and RNA interference technique to inhibit the cellular signal cascade and using the Gαgust−/− mice, we elucidated that GLP-1 secreting effect of Rg3 mediated by the sweet taste receptor mediated the signaling pathway. Rg3, a ginsenoside metabolite that transformed the structure through a steaming process, showed the strongest GLP-1 secreting effects in NCI-H716 cells and also showed an anti-hyperglycemic effect on a type 2 diabetic mouse model through increased plasma GLP-1 and plasma insulin levels during an oral glucose tolerance test. Our study reveals a novel mechanism where the sugar moieties of ginsenosides Rg3 stimulates GLP-1 secretion in enteroendocrine L cells through a sweet taste receptor-mediated signal transduction pathway and thus has an anti-hyperglycemic effect on the type 2 diabetic mouse model.

29 October 2013 in Plant Physiology
Verified
Journal Article
Open access
PDF file
HKHye Gi Kim
Hye Gi Kim
SKSun Jae Kwon
Sun Jae Kwon
YJYoung Jin Jang
Young Jin Jang
MNMyung Hee Nam
Myung Hee Nam
JCJoo Hee Chung
Joo Hee Chung
OPOhkmae K. Park
Ohkmae K. Park
Ethylene is a key signal in the regulation of plant defense responses. It is required for the expression and function of GDSL LIPASE1 (GLIP1) in Arabidopsis (Arabidopsis thaliana), which plays an important role in plant immunity. Here, we explore molecular mechanisms underlying the relationship between GLIP1 and ethylene signaling by an epistatic analysis of ethylene response mutants and GLIP1-overexpressing (35S:GLIP1) plants. We show that GLIP1 expression is regulated by ethylene signaling components and, further, that GLIP1 expression or application of petiole exudates from 35S:GLIP1 plants affects ethylene signaling both positively and negatively, leading to ETHYLENE RESPONSE FACTOR1 activation and ETHYLENE INSENSITIVE3 (EIN3) down-regulation, respectively. Additionally, 35S:GLIP1 plants or their exudates increase the expression of the salicylic acid biosynthesis gene SALICYLIC ACID INDUCTION-DEFICIENT2, known to be inhibited by EIN3 and EIN3-LIKE1. These results suggest that GLIP1 regulates plant immunity through positive and negative feedback regulation of ethylene signaling, and this is mediated by its activity to accumulate a systemic signal(s) in the phloem. We propose a model explaining how GLIP1 regulates the fine-tuning of ethylene signaling and ethylene-salicylic acid cross talk.